CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-01 | CONRAD HERBERT J Director | Grant or award | +26,087 | 3,992,566 | ||
| 2018-09-05 | LEPORE PATRICK G Director | Grant or award · Option (right to buy) | +150,000 | 150,000 | ||
| 2018-06-29 | CONRAD HERBERT J Director | Grant or award | +55,300 | 3,966,479 | ||
| 2018-06-29 | Scibetta James S Director | Grant or award | +43,203 | 486,184 | ||
| 2018-06-29 | WIKLER MATTHEW Director | Grant or award | +32,259 | 50,681 | ||
| 2018-06-29 | Ende Eric J Director | Grant or award | +20,594 | 32,354 | ||
| 2018-06-21 | Scibetta James S Director | Purchase · Series B Convertible Preferred Stock | +12 | $1,000.00 | $12K | 12 |
| 2018-06-21 | MANNINO RAPHAEL J Chief Scientific Officer | Purchase · Series B Convertible Preferred Stock | +10 | $1,000.00 | $10K | 10 |
| 2018-06-21 | STERN ADAM K Director | Purchase · Series B Convertible Preferred Stock | +85 | $1,000.00 | $85K | 85 |
| 2018-06-21 | WIKLER MATTHEW Director | Purchase · Series B Convertible Preferred Stock | +6 | $1,000.00 | $6K | 6 |
| 2018-06-21 | Jabbour Jerome D President and CEO | Purchase · Series B Convertible Preferred Stock | +15 | $1,000.00 | $15K | 15 |
| 2018-06-21 | CONRAD HERBERT J Director | Purchase · Series B Convertible Preferred Stock | +100 | $1,000.00 | $100K | 100 |
| 2018-06-21 | Ende Eric J Director | Purchase · Series B Convertible Preferred Stock | +12 | $1,000.00 | $12K | 12 |
| 2018-04-30 | MANNINO RAPHAEL J Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-04-30 | WIKLER MATTHEW Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2018-04-30 | DiPaolo Dominick Sr. VP-Quality & Manufacturing | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-03-30 | WIKLER MATTHEW Director | Grant or award | +18,422 | 18,422 | ||
| 2018-03-30 | Scibetta James S Director | Grant or award | +24,672 | 442,981 | ||
| 2018-03-30 | CONRAD HERBERT J Director | Grant or award | +31,579 | 3,911,179 | ||
| 2018-03-30 | Ende Eric J Director | Grant or award | +11,760 | 11,760 |
Page 12 of 14 · 264 trades